Alymsys 100 mg/4 mL (25 mg/mL) vial Images
Generic Name: bevacizumab
This medication has been identified as Alymsys 100 mg/4 mL (25 mg/mL) vial. It is supplied by Amneal Pharmaceuticals LLC.
Alymsys is used in the treatment of Glioblastoma Multiforme; Colorectal Cancer; Fallopian Tube Cancer; Cervical Cancer; Non-Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Alymsys 100 mg/4 mL (25 mg/mL) vial is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Alymsys
- Generic Name
- bevacizumab
- Strength
- 100 mg/4 mL (25 mg/mL) vial
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 70121-1754
More about Alymsys (bevacizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Alymsys drug information
- Alymsys (Bevacizumab Intravenous) (Advanced Reading)
- Alymsys (Bevacizumab-maly Intravenous) (Advanced Reading)
Other brands
Avastin, Mvasi, Zirabev, Avzivi, Vegzelma
Professional resources
Other brands
Avastin, Mvasi, Zirabev, Vegzelma
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
